Schedule 13G ownership disclosure

Puma Biotechnology Inc

Security class unavailable · CUSIP: 74587V107

Event date: 2017-05-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,450,968
Percent of class
12.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-17-002487
Form type
SC 13G/A
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
May 26, 2017
Reporting period
May 24, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub